Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases—a Single-Center Study in 190 Patients

INTRODUCTION: Expression of programmed death-ligand 1 (PD-L1) is the only routinely used tissue biomarker for predicting response to programmed cell death protein 1/PD-L1 inhibitors. It is to date unclear whether PD-L1 expression is preserved in brain metastases (BMs). METHODS: In this single-center...

Descripción completa

Detalles Bibliográficos
Autores principales: Kündig, Alexandra, Zens, Philipp, Fung, Christian, Scherz, Amina, Cerciello, Ferdinando, Herrmann, Evelyn, Ermis, Ekin, Schmid, Ralph A., Vassella, Erik, Berezowska, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579806/
https://www.ncbi.nlm.nih.gov/pubmed/36275910
http://dx.doi.org/10.1016/j.jtocrr.2022.100413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579806/
https://www.ncbi.nlm.nih.gov/pubmed/36275910
http://dx.doi.org/10.1016/j.jtocrr.2022.100413

Ejemplares similares